Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct 28:17:2409-2415.
doi: 10.2147/CCID.S489028. eCollection 2024.

D-Penicillamine-Induced Stevens-Johnson Syndrome in a Patient with Gold Cyanide Intoxication: A Case Report

Affiliations
Case Reports

D-Penicillamine-Induced Stevens-Johnson Syndrome in a Patient with Gold Cyanide Intoxication: A Case Report

Tanaporn Anuntrangsee et al. Clin Cosmet Investig Dermatol. .

Abstract

D-penicillamine is used as the mainstay of chelation therapy for Wilson's disease and for heavy metal intoxication. D-penicillamine itself has been noted to cause several systemic side effects as well as symptoms related to the skin. Common cutaneous side effects such as acute hypersensitivity reactions, elastic fiber abnormalities, and bullous diseases have been occasionally described. Herein, we report a case of a 23-year-old Thai female with gold intoxication who developed Stevens-Johnson syndrome (SJS) following the treatment of D-penicillamine. To our knowledge, D-penicillamine-induced SJS is exceptionally rare. To raise awareness of potentially fatal cutaneous adverse drug reaction triggered by D-penicillamine, published literature regarding SJS induced by this agent has also been reviewed. D-penicillamine should be regarded as a possible culprit in patients presenting with SJS following D-penicillamine administration and should be promptly discontinued.

Keywords: chelating agent; cutaneous adverse drug reaction; cyanide; epidermal necrolysis; gold salt; penicillamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that this manuscript was prepared in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Cutaneous manifestation of D-penicillamine-induced Stevens-Johnson syndrome. Clinical features show multiple erythematous to dusky red macules coalescing into patches on the chest, abdomen (A), and back (B) with positive Nikolsky’s sign (B, inset).
Figure 2
Figure 2
Multiple erythematous to dusky red macules coalescing into patches on the palms (A) and soles (B).
Figure 3
Figure 3
Facial involvement together with bilateral conjunctival injections (A). Multiple erosions in the oral cavity and lips, some with overlying hemorrhagic crust (B).

Similar articles

References

    1. Ishak R, Abbas O. Penicillamine revisited: historic overview and review of the clinical uses and cutaneous adverse effects. Am J Clin Dermatol. 2013;14(3):223–233. doi:10.1007/s40257-013-0022-z - DOI - PubMed
    1. Hedera P. Update on the clinical management of Wilson’s disease. Appl Clin Genet. 2017;10:9–19. doi:10.2147/TACG.S79121 - DOI - PMC - PubMed
    1. Mejias SG, Ramphul K. Penicillamine. In: StatPearls. Treasure Island (FL): ineligible companies. Disclosure: Kamleshun Ramphul declares no relevant financial relationships with ineligible companies; 2024.
    1. Friedman M. Chemical basis for pharmacological and therapeutic actions of penicillamine. Adv Exp Med Biol. 1977;86B:649–673. doi:10.1007/978-1-4757-9113-6_36 - DOI - PubMed
    1. Gerhardsson L, Aaseth J. Chapter 7 - guidance for clinical treatment of metal poisonings—use and misuse of chelating agents. In: Aaseth J, Crisponi G, Andersen O, editors. Chelation Therapy in the Treatment of Metal Intoxication. Boston: Academic Press; 2016:313–341.

Publication types

LinkOut - more resources